PD-L1 has been extensively studied as a negative regulator of the immune response that enables tumor cells to escape T cell immunity 66, 67, and as an inducer of peripheral tolerance to prevent autoimmune diseases 66, 68. The gene discussed is CD274; the disease is neoplasm.